Riskpilot
← Back to search
Sign in
Get full access
Pharmaceuticals Sales & Development Sweden AB
AB
Dissolved
Org 5567531412
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2008
0 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Pharmaceuticals Sales & Development Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Revenue 2021
SEK 0
EBITDA margin
—
-103% vs 2020
Equity ratio
100.0%
Financial strength
Net profit 2021
SEK 0
-100% vs 2020
EBITDA — year on year
SEK millions
4M
3M
2M
1M
0M
2M
2017
3M
+50%
2018
3M
0%
2019
1M
-67%
2020
0M
-100%
2021
Key figures
Annual report 2021
Revenue
SEK 0
—
EBITDA
SEK -26K
-103%
Net profit
SEK 0
-100%
Total assets
SEK 4,4M
-7%
Equity
SEK 4,4M
+0%
Employees
0
—
Company information
Legal name
Pharmaceuticals Sales & Development Sweden AB
Org number
5567531412
Legal form
Aktiebolag
NACE code
2120 ·
Manufacture of pharmaceutical preparations
Founded
3 mars 2008
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Bolaget ska utveckla och eller sälja läkemedel samt bedriva därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in
All Sweden companies
Frequently asked questions
What is the Org number of Pharmaceuticals Sales & Development Sweden AB?
Pharmaceuticals Sales & Development Sweden AB is registered with Bolagsverket / SCB under Org 5567531412.
Who is the CEO of Pharmaceuticals Sales & Development Sweden AB?
Rolf Nicklas Kullberg is Chief Auditor of Pharmaceuticals Sales & Development Sweden AB, in role since 2020.
Who is the chairman of Pharmaceuticals Sales & Development Sweden AB?
Anders Leif Håkansson chairs the board of Pharmaceuticals Sales & Development Sweden AB, in role since 2020.
